Biotech product launch announcing a promising new probiotic aimed at addressing immune aging, plus plans to present the formulation to industry partners at a major conference.
Key Takeaways
- 12-week randomized placebo-controlled study reported up to 48% NK cell activity increase
- Participants receiving the probiotic experienced substantially fewer common colds during the intervention
- Market was over USD 35 billion in 2024 and projected to exceed USD 76 billion